NCT01787097View on ClinicalTrials.gov

Effect of Symbicort ® on GR in Sputum in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

April 30, 2015

Conditions
Chronic Obstructive Lung Disease
Interventions
DRUG

Symbicort® total dose 400ug/12ug

Symbicort® is combination of formoterol 400ug and budesonide 12ug. Single dose

DRUG

Symbicort® total dose 800ug/24ug

Symbicort® is combination of formoterol 800ug and budesonide 24ug. Single dose

DRUG

Formoterol 24ug

Turbuhaler

DRUG

BUD total dose 800ug

Turbuhaler

Trial Locations (1)

SW3 6NP

Royal Brompton and Harefield NHS trust, London

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Imperial College London

OTHER